From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
On 24 April, the Arizona Experience website unveils Biotechnology and Life Sciences theme showcasing the organizations, institutions, and research facilities that have helped catapult Arizona to one of the nation’s leading states in biomedical research. Flinn Foundation, AZBio, BIO5 Institute, ASU Biodesign Institute, NAU, and numerous institutions provided their insight and materials in order to […]
The following letter was delivered to leaders in Washington DC thanking them for their efforts on behalf our our industry working in partnership with the FDA and the value to our state and our country on reauthorising the MDUFA and PDUFA user fee agreements.
Molecular alternatives to DNA, RNA offer new insight into life’s origins
Outstanding professors honored for contributions
- TENWEST Impact Festival
- 10/11/2019 - 10/20/2019
- BIO Investor Forum 2019
- 10/22/2019 - 10/23/2019
- San Francisco
- Women’s Angel Investor Forum
- Mini-Medical School - Flinn Foundation Buffmire Lecture
- KOL Luncheon: Breast Cancer Molecular Diagnostics